A descriptive cross-sectional study to evaluate the Generic Drug User Fee Act: A boon or loss to the Indian generic pharmaceutical industry

Sarika Prasanna Pardhe

DOI: 10.7324/JAPS.2019.90206Pages: 044-051

Graphical Abstract